Unknown

Dataset Information

0

Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2.


ABSTRACT: Mutations in the ataxin-2 gene (ATXN2) cause the neurodegenerative disorders amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia type 2 (SCA2). A therapeutic strategy using antisense oligonucleotides targeting ATXN2 has entered clinical trial in humans. Additional ways to decrease ataxin-2 levels could lead to cheaper or less invasive therapies and elucidate how ataxin-2 is normally regulated. Here, we perform a genome-wide fluorescence-activated cell sorting (FACS)-based CRISPR-Cas9 screen in human cells and identify genes encoding components of the lysosomal vacuolar ATPase (v-ATPase) as modifiers of endogenous ataxin-2 protein levels. Multiple FDA-approved small molecule v-ATPase inhibitors lower ataxin-2 protein levels in mouse and human neurons, and oral administration of at least one of these drugs-etidronate-is sufficient to decrease ataxin-2 in the brains of mice. Together, we propose v-ATPase as a drug target for ALS and SCA2 and demonstrate the value of FACS-based screens in identifying genetic-and potentially druggable-modifiers of human disease proteins.

SUBMITTER: Kim G 

PROVIDER: S-EPMC9664452 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


Mutations in the ataxin-2 gene (ATXN2) cause the neurodegenerative disorders amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia type 2 (SCA2). A therapeutic strategy using antisense oligonucleotides targeting ATXN2 has entered clinical trial in humans. Additional ways to decrease ataxin-2 levels could lead to cheaper or less invasive therapies and elucidate how ataxin-2 is normally regulated. Here, we perform a genome-wide fluorescence-activated cell sorting (FACS)-based CRISPR-Cas9  ...[more]

Similar Datasets

2022-10-18 | GSE189417 | GEO
| PRJNA782983 | ENA
| S-EPMC9664481 | biostudies-literature
| S-EPMC7539795 | biostudies-literature
| S-EPMC8203616 | biostudies-literature
| S-EPMC2041992 | biostudies-literature
2022-10-18 | GSE200530 | GEO
| S-EPMC7105297 | biostudies-literature
| S-EPMC8914179 | biostudies-literature
| S-EPMC10140619 | biostudies-literature